Skip to main content
Article thumbnail
Location of Repository

Randomized Phase II Trial of Erlotinib Versus Temozolomide or Carmustine in Recurrent Glioblastoma: EORTC Brain Tumor Group Study 26034

By Martin J. van den Bent, Alba A. Brandes, Roy Rampling, Mathilde C.M. Kouwenhoven, Johan M. Kros, Antoine F. Carpentier, Paul M. Clement, Marc Frenay, Mario Campone, Jean-Francois Baurain, Jean-Paul Armand, Martin J.B. Taphoorn, Alicia Tosoni, Heidemarie Kletzl, Barbara Klughammer, Denis Lacombe and Thierry Gorlia
Topics: Original Reports
Publisher: American Society of Clinical Oncology
OAI identifier: oai:pubmedcentral.nih.gov:2667826
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.